An inhibitor of Bcl-2 family proteins induces regression of solid tumours (original) (raw)

References

  1. Daniel, N. N. & Korsmeyer, S. J. Cell death: critical control points. Cell 116, 205–219 (2004)
    Article Google Scholar
  2. Kirkin, V., Joos, S. & Zörnis, M. The role of Bcl-2 family members in tumorigenesis. Biochim. Biophys. Acta 1644, 229–249 (2004)
    Article CAS PubMed Google Scholar
  3. Amundson, S. A. et al. An informatics approach identifying markers of chemosensitivity in human cancer cell lines. Cancer Res. 60, 6101–6110 (2000)
    CAS PubMed Google Scholar
  4. Reed, J. C. Promise and problems of Bcl-2 antisense therapy. J. Natl Cancer Inst. 89, 988–990 (1997)
    Article CAS PubMed Google Scholar
  5. Letai, A., Sorcinelli, M. D., Beard, C. & Korsmeyer, S. J. Antiapoptotic Bcl-2 is required for maintenance of a model leukemia. Cancer Cell 6, 241–249 (2004)
    Article CAS PubMed Google Scholar
  6. Klasa, R. J., Gillum, A. M., Klem, R. E. & Frankel, S. R. Oblimersen Bcl-2 antisense: facilitating apoptosis in anticancer treatment. Antisense Nucleic Acid Drug Dev. 12, 193–213 (2002)
    Article CAS PubMed Google Scholar
  7. Kutzki, O. et al. Development of a potent Bcl-XL antagonist based on α-helix mimicry. J. Am. Chem. Soc. 124, 11838–11839 (2002)
    Article CAS PubMed Google Scholar
  8. Tzung, S.-P. et al. Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3. Nature Cell Biol. 3, 183–191 (2001)
    Article CAS PubMed Google Scholar
  9. Becattini, B. et al. Rational design and real time, in-cell detection of the proapoptotic activity of a novel compound targeting Bcl-XL . Chem. Biol. 11, 389–395 (2004)
    Article CAS PubMed Google Scholar
  10. Kitada, S. et al. Discovery, characterization, and structure—activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins. J. Med. Chem. 46, 4259–4264 (2003)
    Article CAS PubMed Google Scholar
  11. Wang, J.-L. et al. Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. Proc. Natl Acad. Sci. USA 97, 7124–7129 (2000)
    Article ADS CAS PubMed PubMed Central Google Scholar
  12. Degterev, A. et al. Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-XL . Nature Cell Biol. 3, 173–182 (2001)
    Article CAS PubMed Google Scholar
  13. Enyedy, I. J. et al. Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening. J. Med. Chem. 44, 4313–4324 (2001)
    Article CAS PubMed Google Scholar
  14. Walensky, L. D. et al. Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix. Science 305, 1466–1470 (2004)
    Article ADS CAS PubMed PubMed Central Google Scholar
  15. Baell, J. B. & Huang, D. C. S. Prospects for targeting the Bcl-2 family of proteins to develop novel cytotoxic drugs. Biochem. Pharm. 64, 851–863 (2002)
    Article CAS PubMed Google Scholar
  16. Petros, A. M., Olejniczak, E. T. & Fesik, S. W. Structural biology of the Bcl-2 family of proteins. Biochim. Biophys. Acta 1644, 83–94 (2004)
    Article CAS PubMed Google Scholar
  17. Kelekar, A. & Thompson, C. B. Bcl-2-family proteins: the role of the BH3 domain in apoptosis. Trends Cell Biol. 8, 324–330 (1998)
    Article CAS PubMed Google Scholar
  18. Huang, D. C. & Strasser, A. BH3-only proteins—essential initiators of apoptotic cell death. Cell 103, 839–842 (2000)
    Article CAS PubMed Google Scholar
  19. Sattler, M. et al. Structure of Bcl-XL-Bak peptide complex: Recognition between regulators of apoptosis. Science 275, 983–986 (1997)
    Article CAS PubMed Google Scholar
  20. Shuker, S. B., Hajduk, P. J., Meadows, R. P. & Fesik, S. W. Discovering high-affinity ligands for proteins: SAR by NMR. Science 274, 1531–1534 (1996)
    Article ADS CAS PubMed Google Scholar
  21. Mao, H. et al. Rational design of diflunisal analogues with reduced affinity for human serum albumin. J. Am. Chem. Soc. 123, 10429–10435 (2001)
    Article CAS PubMed Google Scholar
  22. Letai, A. et al. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2, 183–192 (2002)
    Article CAS PubMed Google Scholar
  23. Wei, M. C. et al. Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death. Science 292, 727–730 (2001)
    Article ADS CAS PubMed PubMed Central Google Scholar
  24. Fearon, E. R. et al. Karyoplasmic interaction selection strategy: A general strategy to detect protein-protein interactions in mammalian cells. Proc. Natl Acad. Sci. USA 89, 7958–7962 (1992)
    Article ADS CAS PubMed PubMed Central Google Scholar
  25. Tsujimoto, Y., Finger, L. R., Yunis, J., Nowell, P. C. & Croce, C. M. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 226, 1097–1099 (1984)
    Article ADS CAS PubMed Google Scholar
  26. Petros, A. M. et al. Solution structure of the antiapoptotic protein bcl-2. Proc. Natl Acad. Sci. USA 98, 3012–3017 (2001)
    Article ADS CAS PubMed PubMed Central Google Scholar
  27. Mao, H., Gunasekera, A. H. & Fesik, S. W. Expression, refolding, and isotopic labeling of human serum albumin domains for NMR spectroscopy. Protein Express. Purif. 20, 492–499 (2000)
    Article CAS Google Scholar
  28. Brunger, A. T. X-PLOR Version 3.1 (Yale Univ. Press, New Haven/London, 1992)
    Google Scholar
  29. Zhang, H., Nimmer, P., Rosenberg, S. H., Ng, S.-C. & Joseph, M. Development of a high-throughput fluorescence polarization assay for Bcl-XL . Anal. Biochem. 307, 70–75 (2002)
    Article CAS PubMed Google Scholar
  30. Wang, Z.-X. An exact mathematical expression for describing competitive binding of two different ligands to a protein molecule. FEBS Lett. 360, 111–114 (1995)
    Article CAS PubMed Google Scholar

Download references

Acknowledgements

We thank T. J. Kipps, L. Rassenti, J. Gribben and L. Vallat for CLL Research Consortium samples, E. Monosov for assistance with confocal imaging, C. Rudin and C. Hann for H345 xenograft studies, and S. Ackler for compound formulation.

Author information

Author notes

  1. Tilman Oltersdorf, Steven W. Elmore and Alexander R. Shoemaker: *These authors contributed equally to this work

Authors and Affiliations

  1. Idun Pharmaceuticals, 9380 Judicial Drive, San Diego, California, 92121, USA
    Tilman Oltersdorf, Robert C. Armstrong, Barbara A. Belli, Thomas L. Deckwerth & Kevin J. Tomaselli
  2. Global Pharmaceutical Research & Development, Abbott Laboratories, Abbott Park, Illinois, 60064, USA
    Steven W. Elmore, Alexander R. Shoemaker, David J. Augeri, Milan Bruncko, Jurgen Dinges, Philip J. Hajduk, Mary K. Joseph, Aaron R. Kunzer, Michael J. Mitten, David G. Nettesheim, ShiChung Ng, Paul M. Nimmer, Jacqueline M. O'Connor, Anatol Oleksijew, Andrew M. Petros, Wang Shen, Stephen K. Tahir, Baole Wang, Michael D. Wendt, Haichao Zhang, Stephen W. Fesik & Saul H. Rosenberg
  3. Development, Abbott Laboratories, Abbott Park, Illinois, 60064
    Steven W. Elmore, Alexander R. Shoemaker, David J. Augeri, Milan Bruncko, Jurgen Dinges, Philip J. Hajduk, Mary K. Joseph, Aaron R. Kunzer, Michael J. Mitten, David G. Nettesheim, ShiChung Ng, Paul M. Nimmer, Jacqueline M. O'Connor, Anatol Oleksijew, Andrew M. Petros, Wang Shen, Stephen K. Tahir, Baole Wang, Michael D. Wendt, Haichao Zhang, Stephen W. Fesik & Saul H. Rosenberg
  4. The Burnham Institute, 10901 North Torrey Pines Road, La Jolla, California, 92037, USA
    Shinichi Kitada & John C. Reed
  5. Howard Hughes Medical Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA
    Stanley J. Korsmeyer
  6. Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, USA
    Stanley J. Korsmeyer & Anthony Letai
  7. Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania, 19104, USA
    Chi Li & Craig B. Thompson

Authors

  1. Tilman Oltersdorf
    You can also search for this author inPubMed Google Scholar
  2. Steven W. Elmore
    You can also search for this author inPubMed Google Scholar
  3. Alexander R. Shoemaker
    You can also search for this author inPubMed Google Scholar
  4. Robert C. Armstrong
    You can also search for this author inPubMed Google Scholar
  5. David J. Augeri
    You can also search for this author inPubMed Google Scholar
  6. Barbara A. Belli
    You can also search for this author inPubMed Google Scholar
  7. Milan Bruncko
    You can also search for this author inPubMed Google Scholar
  8. Thomas L. Deckwerth
    You can also search for this author inPubMed Google Scholar
  9. Jurgen Dinges
    You can also search for this author inPubMed Google Scholar
  10. Philip J. Hajduk
    You can also search for this author inPubMed Google Scholar
  11. Mary K. Joseph
    You can also search for this author inPubMed Google Scholar
  12. Shinichi Kitada
    You can also search for this author inPubMed Google Scholar
  13. Stanley J. Korsmeyer
    You can also search for this author inPubMed Google Scholar
  14. Aaron R. Kunzer
    You can also search for this author inPubMed Google Scholar
  15. Anthony Letai
    You can also search for this author inPubMed Google Scholar
  16. Chi Li
    You can also search for this author inPubMed Google Scholar
  17. Michael J. Mitten
    You can also search for this author inPubMed Google Scholar
  18. David G. Nettesheim
    You can also search for this author inPubMed Google Scholar
  19. ShiChung Ng
    You can also search for this author inPubMed Google Scholar
  20. Paul M. Nimmer
    You can also search for this author inPubMed Google Scholar
  21. Jacqueline M. O'Connor
    You can also search for this author inPubMed Google Scholar
  22. Anatol Oleksijew
    You can also search for this author inPubMed Google Scholar
  23. Andrew M. Petros
    You can also search for this author inPubMed Google Scholar
  24. John C. Reed
    You can also search for this author inPubMed Google Scholar
  25. Wang Shen
    You can also search for this author inPubMed Google Scholar
  26. Stephen K. Tahir
    You can also search for this author inPubMed Google Scholar
  27. Craig B. Thompson
    You can also search for this author inPubMed Google Scholar
  28. Kevin J. Tomaselli
    You can also search for this author inPubMed Google Scholar
  29. Baole Wang
    You can also search for this author inPubMed Google Scholar
  30. Michael D. Wendt
    You can also search for this author inPubMed Google Scholar
  31. Haichao Zhang
    You can also search for this author inPubMed Google Scholar
  32. Stephen W. Fesik
    You can also search for this author inPubMed Google Scholar
  33. Saul H. Rosenberg
    You can also search for this author inPubMed Google Scholar

Corresponding authors

Correspondence toStephen W. Fesik or Saul H. Rosenberg.

Ethics declarations

Competing interests

S.W.E., A.R.S., D.J.A., M.B., J.D., P.J.H., M.K.J., A.R.K, M.J.M., D.G.N., S-C.H., P.M.N., J.M.O'C., A.O., A.M.P., W.S., S.K.T., B.W., M.D.W., H.Z., S.W.F. and S.H.R. are current or recent employees of Abbott Laboratories. T.O., K.J.T., R.C.A., B.A.B. and T.L. D. are current or recent employees of Idun Pharmaceuticals.

Supplementary information

Supplementary Figure S1

This figure summarizes the synthetic scheme for the chemical synthesis of ABT-737. (PDF 28 kb)

Supplementary Figure S2

This figure contains NMR-derived structures that illustrate the differences between the binding pockets of Bcl-2 and Bcl-XL. (PPT 2187 kb)

Supplementary Figure S3

This figure illustrates the effects of ABT-737 on cytochrome c release from mitochondria isolated from Bak-/-Bax-/- cells that had been stably transfected with either Bak, Bax, or a control plasmid. (PPT 943 kb)

Supplementary Figure S4

This figure illustrates the enhanced survival effected by ABT-737 in the DoHH-2 systemic model of B-cell Lymphoma. (PPT 35 kb)

Supplementary Tables S1-S5

This file contains NMR and structural statistics for the protein complexes illustrated in Figure 1 and Supplementary Figure 2. (DOC 64 kb)

Supplementary Figure Legends

Legends for Supplementary Figures S1-S4. (DOC 56 kb)

Rights and permissions

About this article

Cite this article

Oltersdorf, T., Elmore, S., Shoemaker, A. et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours.Nature 435, 677–681 (2005). https://doi.org/10.1038/nature03579

Download citation